Literature DB >> 6990251

[Effect of smoking-machine parameters on the genetoxic activity of cigarette gas phase, estimated on human lymphocyte and yeast (author's transl)].

C Izard, D Valadaud-Barrieu, J P Fayeulle, A Testa.   

Abstract

Cigarette smoke used in chemical research and bioassays is obtained by mechanical smoking on machines adjusted to international standards. On studying the behavior of some smokers of black tobacco, we were led to change the standard parameters: volume, duration, frequency. The gas phase obtained under those new conditions is poorer in some components. This decrease goes with a clear-cut decrease of its genotoxic activity towards cultured human lymphocytes (sister-chromatid exchange frequency) and S. cerevisiae (rate of mitotic recombinants and of respiratory deficients). This investigation emphasizes the leading part of the smoking behavior.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6990251     DOI: 10.1016/0165-1218(80)90005-1

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  3 in total

1.  Cytogenetic effects of cigarette smoke condensates in vitro and in vivo.

Authors:  S Madle; A Korte; G Obe
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

2.  Stereochemistry modulates the stability of reduced interstrand cross-links arising from R- and S-alpha-CH3-gamma-OH-1,N2-propano-2'-deoxyguanosine in the 5'-CpG-3' DNA sequence.

Authors:  Young-Jin Cho; Ivan D Kozekov; Thomas M Harris; Carmelo J Rizzo; Michael P Stone
Journal:  Biochemistry       Date:  2007-02-17       Impact factor: 3.162

3.  Stereospecific formation of interstrand carbinolamine DNA cross-links by crotonaldehyde- and acetaldehyde-derived alpha-CH3-gamma-OH-1,N2-propano-2'-deoxyguanosine adducts in the 5'-CpG-3' sequence.

Authors:  Young-Jin Cho; Hao Wang; Ivan D Kozekov; Andrew J Kurtz; Jaison Jacob; Markus Voehler; Jarrod Smith; Thomas M Harris; R Stephen Lloyd; Carmelo J Rizzo; Michael P Stone
Journal:  Chem Res Toxicol       Date:  2006-02       Impact factor: 3.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.